Alternatively, Song and coworkers [300] reported HDAC inhibitor-stimulated increase of NKG2D ligand expression on the surface of ovarian cancer cells, which allowed for better recognition and killing of the latter by engineered NGK2DL-specific chimeric antigen receptor T cells. Here, HDAC9 is linked to ovarian cancer.